Inactive Instrument

Insiders KetamineOne Capital Deutsche Boerse AG

Equities

Wellbeing Digital Sciences Inc. Appoints Mohammad Sharifi to Board of Directors	22-11-22	CI
Wellbeing Digital Sciences Inc. Announces Management Changes	22-11-18	CI
Wellbeing Digital Sciences Inc. Appoints Najla Guthrie to the Benzinga Psychedelic Advisory Council	22-08-30	CI
Wellbeing Digital Sciences Appoints Natalie Dolphin as VP of Marketing and Investment Relations	22-06-21	CI
Wellbeing Digital Sciences Announces the Appointment of Terry Zimaro as Chief Financial Officer	22-06-15	CI
Wellbeing Digital Sciences Inc. Announces Resignation Joseph Ramelli as Chief Financial Officer	22-05-27	CI
Wellbeing Digital Sciences Inc. Appoints Michael Ho as the New Medical Director, Effective May 2, 2022	22-05-03	CI
Wellbeing Digital Sciences Announces CEO Changes, Effective March 31, 2022	22-03-07	CI
KetamineOne Capital Limited has Changed its Name to Wellbeing Digital Sciences Inc	22-01-24	CI
KetamineOne Capital Limited Announces Management Appointments	22-01-05	CI
KetamineOne Capital Limited Announces Departure of Mark Kimmins as Chief Medical Officer	21-12-16	CI
KetamineOne Capital Limited Appoints Joe Ramelli as Its New Chief Financial Officer	21-12-14	CI
Ketamine One Announces Resignation of Loreto Grimaldi from Board of Directors	21-11-04	CI
Auralite Investments Inc. Announces Management Changes	19-01-29	CI
Auralite Investments Inc. Announces Management Changes	18-12-19	CI
Cabernet Capital Corp. has Changed its Name to Auralite Investments Inc	18-09-07	CI

No results for this search